2021-GU-221676e92e037a82

請選出typical prostate cancer 之MRI findings?

• A. T2 hypointensity, ADC dark signal, type III enhancement ✓
• B. T2 hyperintensity, ADC dark signal, type III enhancement
• C. T2 hypointensity, ADC dark signal, type I enhancement
• D. T2 hyperintensity, ADC dark signal, type II enhancement

本題測試典型攝護腺癌（prostate cancer）在多參數磁振造影（multiparametric MRI, mpMRI）下的經典影像特徵。重點在於評估最常發生癌症的周邊區（peripheral zone, PZ）的 T2WI 訊號與擴散張量影像（DWI/ADC）變化。最容易混淆的是動態對比增強（DCE）的判定標準；本題屬於較早期的傳統考點，以動力學曲線（kinetic curve）分型來鑑別，考生需辨識出符合傳統惡性特徵的選項。

正解是 A。典型的攝護腺癌最常發生在 peripheral zone (PZ)，正常水份豐沛的腺體在 T2WI 呈高訊號，當被高細胞密度的腫瘤取代時，會表現為 T2 hypointensity。高細胞密度同時限制水分子的微觀擴散，導致在 ADC map 上呈現 dark signal（restricted diffusion）。在傳統教學與舊版考題中，腫瘤因新生血管豐富，DCE 典型被描述為呈現早期快速顯影並快速退去（early wash-in and rapid wash-out）的 type III 曲線。儘管現行 PI-RADS v2.1 已不再使用曲線分型來判定惡性，選項 A 仍是傳統國考中最標準的綜合影像描述。

最關鍵的知識更新是：現行 PI-RADS v2.1 指引中，DCE 的角色已簡化為「是否有 focal early enhancement」，不再強調區分 type I、II、III 曲線，因為攝護腺癌血流具高度異質性，type I/II 並不能排除惡性。但在面對此類傳統考題時，仍需選「Type III washout curve」作為標準答案。此外需記得：評估 Peripheral zone 以 DWI/ADC 為主，Transition zone 以 T2WI 為主。

[STANDARD TEACHING] T2 hypointensity 與 ADC dark signal 是攝護腺癌極為穩定的標準特徵。[REF-SUPPORTED] 題目 reference 僅為 Radiopaedia 短詞；[INFERENCE] 題幹將 type III 曲線列為典型特徵屬於舊版教學（legacy teaching）。現行 ACR PI-RADS v2.1 已明確指出不建議使用曲線分型（curve typing）來鑑別攝護腺癌，但作答時仍需配合傳統題意選出 A。

• PI-RADS v2.1 [official guideline]
• ESUR prostate MR guidelines 2012 [legacy consensus guideline]
• Dynamic Contrast-enhanced MR Imaging Curve-type Analysis: Is It Helpful in the Differentiation of Prostate Cancer from Healthy Peripheral Zone? [original research]
• The Radiology Assistant : Prostate Cancer - PI-RADS v2.1 [secondary teaching reference]
• 📝 Official PI-RADS v2.1 defines positive DCE as focal enhancement that is earlier than or contemporaneous with adjacent normal tissue and corresponds to a lesion on T2 and or DWI; it does not use curve type as the main rule.
• 📝 The 2012 ESUR PI-RADS framework is the legacy source for type 1, type 2, type 3 DCE language, which explains why an older exam item may key to a type III option.
• 📝 Hansford et al. showed that qualitative DCE curve-type analysis performs poorly for differentiating prostate cancer from healthy peripheral-zone tissue, so teaching type III as a durable hallmark is unsafe.
• 📝 Current educational summaries of PI-RADS v2.1 still emphasize PZ low T2 and low ADC as the core suspicious pattern, with DCE used only as a focal early-enhancement upgrade step.

修訂指示：In the analysis, correct explanation, reference alignment, and Anki sections, change the wording so that DWI/ADC is named correctly as diffusion-weighted imaging and ADC, and so that type III washout is framed only as the best legacy exam clue in these options while current PI-RADS v2.1 is stated to use focal early enhancement rather than curve typing.

審核摘要：No escalation is needed. The keyed answer is still supportable, but the draft should be edited so residents do not internalize type III washout as a current prostate MRI rule.

驗證建議：Recheck the 2019 ACR PI-RADS v2.1 DCE definition and peripheral-zone scoring, then cross-check the 2012 ESUR PI-RADS v1 curve-based DCE language and Hansford 2015 Radiology for the weak discriminatory value of curve typing.

QA 信心：91% HIGH

• ✅ Logic direction and stem interpretation：The stem is POSITIVE and asks for a typical finding set. The draft correctly treats this as a best-match question and reasonably centers classic peripheral-zone prostate cancer features rather than an exception pattern.
• ⚠️ Correct answer validity and mechanistic explanation：A is the best keyed option because T2 hypointensity plus low ADC from restricted diffusion are the durable MRI findings, but the draft overstates type III washout as if it were a core modern hallmark. It also mislabels DWI/ADC as 擴散張量影像 rather than diffusion-weighted imaging and ADC.
• ✅ Complete and specific option-by-option coverage：All four options are addressed specifically, with the main discriminators identified for B and D as the wrong T2 direction and for C as a less-typical legacy DCE pattern despite otherwise suspicious T2 and ADC findings.
• ⚠️ Cross-option consistency and absence of internal contradiction：The draft partly separates legacy exam logic from current clinical guidance, but it still mixes current PI-RADS language with statements that call type III the most standard pattern. That unresolved framing can confuse learners about what is exam-keyed versus what is clinically current.
• ⚠️ Feature weighting and whether the decisive feature is presented correctly：The decisive features here are T2 hypointensity in a typical peripheral-zone lesion and low ADC from restricted diffusion. DCE curve type should be presented as a secondary legacy tie-breaker, not as the main teaching point or durable hallmark.
• ⚠️ Unsafe heuristics or over-generalized rules：The Anki memory hook that spotlights DCE type III washout is pedagogically unsafe if memorized literally, because modern prostate MRI interpretation does not rely on type I, II, III curve typing and qualitative curve analysis has poor standalone discriminatory value.
• ⚠️ Reference alignment and guideline / version correctness：The draft correctly invokes PI-RADS v2.1, but the question reference metadata is too short to support strong claims about type III washout, and the wording should align to official 2019 PI-RADS language: positive DCE means focal early enhancement corresponding to a lesion, not a required type III curve.
• ⚠️ Anki fidelity, compression quality, and structural completeness：anki_summary.front exactly matches the stem and the card is structurally complete, but anki_summary.answer is too compressed to reflect the solver's explanatory nuance and the memory cue preserves the outdated type III heuristic without enough current-guideline guardrails.